COVID-19 remains a highly preventable and treatable condition and the ill-advised plan to encourage vaccine boosters lacks medical justification, further eroding the public’s trust in our public health authorities.    

WASHINGTON, D.C. – As COVID-19 cases and hospitalizations continue to rise across the United States, the FLCCC reminds the public that even with the new variant, COVID-19 remains a highly preventable and treatable condition. Moreover, given the potential risk of adverse events associated with the COVID-19 vaccines, there remains no medical justification for getting vaccinated or boosted for the COVID-19 virus given the known potential risk of an adverse event.

According to data released by Pfizer in 2022, approximately one to one-and-a-half percent of COVID-19 vaccinations resulted in adverse medical events during the company’s vaccine trial. Although published research shows that the system’s limitation underreports by approximately 30-fold [1], the U.S. government’s Vaccine Adverse Events Reporting System shows that over 1.2 million adverse events associated with the vaccine have been reported since COVID-19 vaccinations became available to the public.

The FLCCC I-PREVENT COVID, FLU RSV, and I-CARE protocols effectively prevent and treat COVID-19. Basing their recommendations on more than 300 published studies, the protocols were developed by a team of the world’s leading physicians and medical scientists to be used by the public to protect themselves from the COVID-19 virus.

“The FLCCC protocols are the most potent, safe, and synergistic prevention and treatment practices we know of that use 43 therapies backed by clinical trial data,” said Pierre Kory, MD, MPA, president and chief medical officer of the FLCCC. “My colleagues and I see patients daily suffering from what many times are debilitating side effects from the COVID vaccines. It is unconscionable to me how our government can continue recommending these vaccines given the risk to the public’s health.”

“I am deeply troubled that our government and health authorities remain committed to the vaccine as being protective against the COVID-19 virus,” said Paul Marik, MD, chairman and chief scientific officer of the FLCCC. “Our health agencies should be looking for opportunities to rebuild the public’s trust in them. Promoting a deeply flawed and dangerous vaccine is not the way to do that.”

In May 2022, the FLCCC released its protocol to treat those suffering from side effects from the COVID-19 vaccines, a condition identified as “Post-Vaccine Syndrome.” The protocol, called I-RECOVER: Post-Vaccine Treatment, uses a combination of FDA-approved medications and widely available supplements to treat the growing number of patients suffering from a broad range of symptoms following COVID-19 vaccination. More information about the I-RECOVER: Post-Vaccine Treatment protocol can be found here:

[1]Rose J. A report on the U.S. Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 messenger ribonucleic acid 9mRNA) biologicals. Science, Public Health Policy, and Law 2021; 2:59-80.

About the Front Line COVID-19 Critical Care Alliance

The FLCCC Alliance was organized in March 2020 by a group of highly published, world renowned critical care physicians and scholars with the academic support of allied physicians from around the world. FLCCC’s goal is to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness including the I-RECOVER protocols for “Long COVID” and Post Vaccine Syndrome. For more information:

Explore Similar Stories